128 related articles for article (PubMed ID: 15459901)
1. Parenteral exposure to high HIV viremia leads to virus-specific T cell priming without evidence of infection.
Missale G; Papagno L; Penna A; Pilli M; Zerbini A; Vitali P; Pieroni G; Urbani S; Uggeri J; Pinheiro S; Rowland-Jones S; Ferrari C
Eur J Immunol; 2004 Nov; 34(11):3208-15. PubMed ID: 15459901
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
Zhang Z; Zhao QX; Fu JL; Yao JX; He Y; Jin L; Wang FS
Chin Med J (Engl); 2006 Dec; 119(23):1949-57. PubMed ID: 17199938
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
[TBL] [Abstract][Full Text] [Related]
4. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
[TBL] [Abstract][Full Text] [Related]
5. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
Lascar RM; Lopes AR; Gilson RJ; Dunn C; Johnstone R; Copas A; Reignat S; Webster G; Bertoletti A; Maini MK
J Infect Dis; 2005 Apr; 191(7):1169-79. PubMed ID: 15747254
[TBL] [Abstract][Full Text] [Related]
6. CD8 T-cell responses in early HIV-1 infection are skewed towards high entropy peptides.
Bansal A; Gough E; Sabbaj S; Ritter D; Yusim K; Sfakianos G; Aldrovandi G; Kaslow RA; Wilson CM; Mulligan MJ; Kilby JM; Goepfert PA
AIDS; 2005 Feb; 19(3):241-50. PubMed ID: 15718834
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
8. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
[TBL] [Abstract][Full Text] [Related]
9. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
[TBL] [Abstract][Full Text] [Related]
10. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
Höhn H; Kortsik C; Tully G; Nilges K; Necker A; Freitag K; Neukirch C; Galle P; Löhr H; Maeurer MJ
Eur J Immunol; 2003 Jun; 33(6):1613-23. PubMed ID: 12778479
[TBL] [Abstract][Full Text] [Related]
13. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
Sprengers D; van der Molen RG; Kusters JG; De Man RA; Niesters HG; Schalm SW; Janssen HL
J Hepatol; 2006 Aug; 45(2):182-9. PubMed ID: 16516331
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
15. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
[TBL] [Abstract][Full Text] [Related]
16. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma (IFN-gamma) response to different hepatitis B virus antigens in hepatitis B virus infection.
Paul S; Tabassum S; Islam MN
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):71-7. PubMed ID: 15813485
[TBL] [Abstract][Full Text] [Related]
18. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
19. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM
J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
